Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Julie Frances Reeves has worked on the following 6 EPO patent applications which have been published in the last five years:

EP12822519

ANTIOXIDANT TOPICAL COMPOSITIONS

IPC classification:
A61K 8/34, A61K 8/67, A61K 9/12, A61P 17/00, A61Q 19/00, A61Q 19/08
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15151851

Dispensers for Tissue Dilator Devices

IPC classification:
A61F 5/08, A61F 13/00, A61F 13/12, A61F 15/00, B65H 5/28, G07F 11/66
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14754670

NON-AQUEOUS SOLID STABILIZED EMULSIONS

IPC classification:
A61K 8/04, A61K 8/25
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14714047

DYE FREE LIQUID THERAPEUTIC SOLUTION

IPC classification:
A61K 9/08, A61K 31/167, A61K 47/10, A61K 47/26
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14795047

NICOTINE LOZENGE FORMULATION

IPC classification:
A61K 9/20, A61K 31/465
Applicant:
GlaxoSmithKline LLC
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15767328

TOPICAL DICLOFENAC SODIUM COMPOSITIONS

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/107, A61K 31/196, A61P 19/02, A61P 29/00
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature